Dihydropyrimidine dehydrogenase deficiency is a rare genetic disorder that affects the body's ability to break down certain pyrimidine bases, leading to an accumulation of uracil and thymine in the body. This deficiency can result in severe toxic reactions to fluoropyrimidine drugs, such as 5-fluorouracil, used in cancer treatment due to impaired drug metabolism.